| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |